Earnings before interest, tax, depreciation and amortisation or Ebitda during the quarter increased 38% from a year earlier to ₹3,908 crore. Ebitda margin improved by 190 basis points (bps) to 11.7% from 9.8% helped by easing commodity prices, improved capacity utilisation, cost reduction efforts and improved realisation.
MARUTI Q3 Results: Check out Maruti Suzuki India Q3 Result news, Maruti Suzuki India Q3 Earnings result updates and highlights. | MARUTI Q3 Results 2023
Sun Pharmaceuticals and Maruti Suzuki India are among the companies declaring their Q3FY24 earnings. Maruti Suzuki India is expected to report healthy revenue growth, while Sun Pharmaceuticals may see moderate revenue growth.